Head-to-head
CoreAge Rx vs Belle Health
CoreAge Rx and Belle Health both offer GLP-1 telehealth, but they make different trade-offs on speed to first dose, flat pricing, access and molecule choice. Here they are side-by-side on the Rx-Readiness Score — our readiness rubric.
CoreAge Rx
Higher scoreRanked #1 · Grade A
Best for: Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Visit CoreAge RxBelle Health
Ranked #29 · Grade C
Best for: Working moms who want flat pricing plus dietitian support and are comfortable weighing an established operator against an open (not closed-out) FDA finding.
Visit Belle HealthThe verdict
CoreAge Rx edges out Belle Health on the Rx-Readiness Score, 95 to 65 (A vs C). Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Belle Health is still a genuine option — flat-rate pricing with a real dietitian included ($119/mo semaglutide, from $175/mo tirzepatide) from a nine-year-old operator — carrying an open FDA warning letter over how it described its own compounded products. Weigh the six readiness factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same readiness rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | CoreAge Rx | Belle Health |
|---|---|---|
| Rx-Readiness Score | 95/100 · A | 65/100 · C |
| Overall rank | #1 | #29 |
| Semaglutide | $99/mo | $119/mo flat, all doses |
| Tirzepatide | $149/mo | From $175/mo |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
CoreAge Rx
Ranked #1 · Grade A
What we like
- Flat monthly price that stays put through titration — no dose-scaling surprise on your busiest month
- Both compounded semaglutide and tirzepatide on one plan, so you're not re-signing to switch
- Async, no-video intake and all-50-states coverage — start it during a lunch break
The caveats
- Not the rock-bottom sticker price — a couple of teaser tiers elsewhere start lower
- Compounded only — no FDA-approved brand option
- General metabolic program, not a boutique concierge service
Belle Health
Ranked #29 · Grade C
What we like
- Flat-rate pricing — cost doesn't rise as your provider increases your dose
- Weekly registered-dietitian check-ins included at no extra cost
- Operating since 2017 with over 50,000 patients claimed; names five compounding pharmacy partners in its Terms
The caveats
- FDA Warning Letter 721795 (Feb 2026) found its marketing suggested Belle manufactured its own compounded products — misbranding under FDCA 502(a)/502(bb); no closeout letter published as of this check
- No brand-name (FDA-approved) option and no oral form
- Tirzepatide's exact current price is ambiguous between the homepage's 'from $175/mo' and an earlier-recorded $199/mo 3-month-bundle figure — confirm the live tier at signup
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and Belle Health against other providers on our shortlist.
Or browse the full comparison hub.